← Leaderboards
Lucas R. Hoffman
University Of Washington
$5,810,954
Attributed
$7,418,297
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,731,919 · 8
By mechanism
R01$4,798,017 · 2
P30$2,350,097 · 3
K24$804,423 · 1
K02$400,464 · 1
K08$378,918 · 1
Top collaborators
- Samuel I. Miller5 shared
- Christopher Hooper Goss1 shared
Most similar at University Of Washington
Same institution · by research overlap
- David W Raible$21,473,931
- Edwin W Rubel$15,520,530
- Margaret Rosenfeld$6,120,159
- Lisa L Cunningham$2,377,881
- Margaret McLean Heitkemper$19,105,705
Others in their field
Top investigators on “Cystic Fibrosis”
- John F Engelhardt · University Of Iowa$42,933,706
- Michael R Knowles · University Of North Carolina Chapel Hill$30,250,682
- David A Stoltz · University Of Iowa$25,455,359
- Joseph Zabner · University Of Iowa$25,382,103
- Paul B McCray · University Of Iowa$25,146,293
- Richard C Boucher · University Of North Carolina Chapel Hill$24,890,955
Research focus
Cystic FibrosisClinical ResearchAntibioticsMicrobialLinkResourcesBacteriaMicrobiologyChildFundingAntibiotic TherapyPathogenGrowthLungPhenotypeClinical DataLifeLung DiseasesLife ExpectancyClinical TrialsMorbidity - Disease RateGastrointestinalChildren With Cystic FibrosisEarly Cystic Fibrosis
Grant awards (29)
Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator Era$1,313,622
P30 · FY2025 · DK
Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric disease$125,068
K24 · FY2025 · HL · contact PI
Host Microbe Core$207,295
P30 · FY2024 · DK · contact PI
Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric disease$125,068
K24 · FY2024 · HL · contact PI
Host Microbe Core$207,295
P30 · FY2023 · DK · contact PI
Host Microbe Core$207,295
P30 · FY2022 · DK · contact PI
Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric disease$107,408
K24 · FY2022 · HL · contact PI
Host Microbe Core$207,295
P30 · FY2021 · DK · contact PI
Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric disease$110,292
K24 · FY2021 · HL · contact PI
Host Microbe Core$207,295
P30 · FY2020 · DK · contact PI
Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric disease$111,341
K24 · FY2020 · HL · contact PI
Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric disease$111,740
K24 · FY2019 · HL · contact PI
The relationship of fecal microbiomes and nutritional status in CF$619,708
R01 · FY2018 · DK · contact PI
Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric disease$113,506
K24 · FY2018 · HL · contact PI
The relationship of fecal microbiomes and nutritional status in CF$619,708
R01 · FY2017 · DK · contact PI
The relationship of fecal microbiomes and nutritional status in CF$653,525
R01 · FY2016 · DK · contact PI
The relationship of fecal microbiomes and nutritional status in CF$645,802
R01 · FY2015 · DK · contact PI
The relationship of fecal microbiomes and nutritional status in CF$675,943
R01 · FY2014 · DK · contact PI
Pseudomonas Aeruginosa Early CF Adaptive Changes: A Translational Study$100,116
K02 · FY2014 · HL · contact PI
Pseudomonas Aeruginosa Early CF Adaptive Changes: A Translational Study$100,116
K02 · FY2013 · HL · contact PI
Pseudomonas aeruginosa Adaptation During Early CF Airway Infection and Treatment$383,041
R01 · FY2012 · HL · contact PI
Pseudomonas Aeruginosa Early CF Adaptive Changes: A Translational Study$100,116
K02 · FY2012 · HL · contact PI
Pseudomonas aeruginosa Adaptation During Early CF Airway Infection and Treatment$389,920
R01 · FY2011 · HL · contact PI
Pseudomonas aeruginosa early CF adaptive changes: A translational study$100,116
K02 · FY2011 · HL · contact PI
Pseudomonas aeruginosa Adaptation During Early CF Airway Infection and Treatment$390,830
R01 · FY2010 · HL · contact PI
Pseudomonas aeruginosa Adaptation During Early CF Airway Infection and Treatment$419,540
R01 · FY2009 · HL · contact PI
Antibiotic-mediated Adaptation of Pseudomonas aeruginosa$126,306
K08 · FY2007 · AI · contact PI
Antibiotic-mediated Adaptation of Pseudomonas aeruginosa$126,306
K08 · FY2006 · AI · contact PI
Antibiotic-mediated Adaptation of Pseudomonas aeruginosa$126,306
K08 · FY2005 · AI